GC Wealth Management RIA’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Sell
4,478
-68
-1% -$4.53K 0.02% 412
2026
Q1
$285K Sell
4,546
-976
-18% -$68K 0.01% 443
2025
Q4
$366K Sell
5,522
-2,500
-31% -$162K 0.01% 421
2025
Q3
$540K Buy
8,022
+3,867
+93% +$306K 0.02% 539
2025
Q2
$363K Buy
4,155
+1,226
+42% +$96.1K 0.03% 394
2025
Q1
$200K Buy
2,929
+187
+7% +$15.3K 0.04% 301
2024
Q4
$213K Sell
2,742
-242
-8% -$17.9K 0.04% 278
2024
Q3
$200K Buy
2,984
+538
+22% +$44.2K 0.03% 290
2024
Q2
$277K Sell
2,446
-287
-11% -$36.3K 0.05% 237
2024
Q1
$379K Buy
2,733
+32
+1% +$4.02K 0.08% 191
2023
Q4
$335K Buy
+2,701
New +$276K 0.15% 149

Other funds holding DXCM

GC Wealth Management RIA's DXCM Position: Q2 2026 in Review

GC Wealth Management RIA reduced its DexCom (DXCM) stake by 1.5% in Q2 2026, selling an estimated $4.53K and leaving 4,478 shares worth $302K. The position accounts for 0.02% of the portfolio, ranked #412.

GC Wealth Management RIA first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $540K in Q3 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • GC Wealth Management RIA held 4,478 shares of DexCom worth $302K as of Q2 2026.
  • GC Wealth Management RIA sold 68 DexCom shares in Q2 2026, an estimated $4.53K.
  • DexCom made up 0.02% of GC Wealth Management RIA's portfolio in Q2 2026, its #412 holding.
  • GC Wealth Management RIA first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • GC Wealth Management RIA's DexCom position peaked at $540K in Q3 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.